匯豐研究:下調華能(0902.HK)目標價至4.4港元 評級“持有”
匯豐研究報告指,華能(00902.HK)第三季盈利温和復甦,主因受到燃料成本單位下跌,華能預料勢頭將持續至今年第四季,仍然維持此前單位燃料成本按年下跌7%的全年指引,因此,該行相信華能今年盈利復甦進展仍如期。
不過該行指,華能過去一個月股價已下跌13%,而由於內地宣佈2020年將推新制度,暫仍未知悉費率(tariff)將下調多少,因此,仍成為華能股價的存在憂隱。雖然華能第三季業績合理,但對煤電獨立電力生產商明年的疲弱盈利前景仍感審慎,故將華能目標價由5.1港元下調至4.4港元,維持評級“持有”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.